A sub-group of patients with hospital-acquired pneumonia do not require broad-spectrum Gram-negative antimicrobial coverage

Clark D Russell, Ed Whittaker, Dominic P Dee, Eilidh Farquhar, Alba Saenz de Villaverde, Morgan H Evans, Ian F Laurenson, Claire L Mackintosh, Muge Cevik

Research output: Contribution to journalArticlepeer-review

1 Downloads (Pure)

Abstract

Among 200 patients developing hospital-acquired pneumonia (HAP) outside the intensive care unit, 61% were treated empirically without broad-spectrum Gram-negative coverage, with clinical cure in 69.7%. Lower disease severity markers (systemic inflammatory response syndrome, hypoxia, tachypnoea, neutrophilia) and the absence of diabetes mellitus and prior doxycycline treatment (but not the time to HAP onset) identified patients not requiring broad-spectrum Gram-negative coverage.
Original languageEnglish
Article numberciaa391
Number of pages4
JournalClinical Infectious Diseases
VolumeAdvance Article
Early online date8 Apr 2020
DOIs
Publication statusE-pub ahead of print - 8 Apr 2020

Keywords

  • Hospital-acquired pneumonia
  • Gram-negative bacteria
  • Doxycycline
  • Gentamicin
  • Antimicrobial stewardship

Fingerprint

Dive into the research topics of 'A sub-group of patients with hospital-acquired pneumonia do not require broad-spectrum Gram-negative antimicrobial coverage'. Together they form a unique fingerprint.

Cite this